MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with O

Ondansetron

Ondansetron 4mg oral lyophilisates sugar free

Incompatible

Stability notes for Ondansetron 4mg oral lyophilisates sugar free

Formulation not suitable for use in MCAs.  No stability data in MCAs available.

Provenance

This recommendation is based on the products Ametron Melt 4mg and 8mg oral lyophilisate (TriOn Healthcare Limited).

Suppliers (4) of Ondansetron 4mg oral lyophilisates sugar free
Ametron Melt 4mg oral lyophilisates (TriOn Pharma Ltd)
Zofran Melt 4mg oral lyophilisates (Abacus Medicine Ltd)
Zofran Melt 4mg oral lyophilisates (CST Pharma Ltd)
Zofran Melt 4mg oral lyophilisates (Necessity Supplies Ltd)

Ondansetron 4mg orodispersible films sugar free

No stability information

Stability notes for Ondansetron 4mg orodispersible films sugar free

There are no stability notes for this medicine.

Suppliers

Setofilm 4mg orodispersible films (Necessity Supplies Ltd)
Setofilm 4mg orodispersible films (Norgine Pharmaceuticals Ltd)

Ondansetron 4mg orodispersible tablets

No stability information

Stability notes for Ondansetron 4mg orodispersible tablets

There are no stability notes for this medicine.

Suppliers (8) of Ondansetron 4mg orodispersible tablets
Ondansetron 4mg orodispersible tablets (A A H Pharmaceuticals Ltd)
Ondansetron 4mg orodispersible tablets (Alliance Healthcare (Distribution) Ltd)
Ondansetron 4mg orodispersible tablets (Healthcare Pharma Ltd)
Ondansetron 4mg orodispersible tablets (Medihealth (Northern) Ltd)
Ondansetron 4mg orodispersible tablets (Morningside Healthcare Ltd)
Ondansetron 4mg orodispersible tablets (Phoenix Healthcare Distribution Ltd)
Ondansetron 4mg orodispersible tablets (Sigma Pharmaceuticals Plc)
Ondansetron 4mg orodispersible tablets (Zentiva Pharma UK Ltd)

Ondansetron 4mg tablets

Use with caution

Stability notes for Ondansetron 4mg tablets

Light sensitive medicine. Store in light resistant container.   Moisture sensitive medicine. Store in airtight (sealed) MCA.  Manufacturer recommends storing in original container. No stability data in MCAs available.

Provenance

This recommendation is based on the products ondansetron 8mg tablets (Aurobindo Pharma - Milpharm Ltd) and ondansetron 4mg and 8mg tablets (Cipla EU Ltd).

Suppliers (14) of Ondansetron 4mg tablets
Ondansetron 4mg tablets (A A H Pharmaceuticals Ltd)
Ondansetron 4mg tablets (Alissa Healthcare Research Ltd)
Ondansetron 4mg tablets (Alliance Healthcare (Distribution) Ltd)
Ondansetron 4mg tablets (Almus Pharmaceuticals Ltd)
Ondansetron 4mg tablets (Bristol Laboratories Ltd)
Ondansetron 4mg tablets (Cipla EU Ltd)
Ondansetron 4mg tablets (Crescent Pharma Ltd)
Ondansetron 4mg tablets (Ennogen Healthcare International Ltd)
Ondansetron 4mg tablets (Medihealth (Northern) Ltd)
Ondansetron 4mg tablets (Milpharm Ltd)
Ondansetron 4mg tablets (Phoenix Healthcare Distribution Ltd)
Ondansetron 4mg tablets (Relonchem Ltd)
Ondansetron 4mg tablets (Sigma Pharmaceuticals Plc)
Ondansetron 4mg tablets (Teva UK Ltd)

Ondansetron 8mg oral lyophilisates sugar free

Incompatible

Stability notes for Ondansetron 8mg oral lyophilisates sugar free

Formulation not suitable for use in MCAs.  No stability data in MCAs available.

Provenance

This recommendation is based on the products Ametron Melt 8mg oral lyophilisate (TriOn Healthcare Limited).

Suppliers

Ametron Melt 8mg oral lyophilisates (TriOn Pharma Ltd)
Zofran Melt 8mg oral lyophilisates (Abacus Medicine Ltd)
Zofran Melt 8mg oral lyophilisates (CST Pharma Ltd)

Ondansetron 8mg orodispersible films sugar free

No stability information

Stability notes for Ondansetron 8mg orodispersible films sugar free

There are no stability notes for this medicine.

Supplier

Setofilm 8mg orodispersible films (Norgine Pharmaceuticals Ltd)

Ondansetron 8mg orodispersible tablets

No stability information

Stability notes for Ondansetron 8mg orodispersible tablets

There are no stability notes for this medicine.

Suppliers (7) of Ondansetron 8mg orodispersible tablets
Ondansetron 8mg orodispersible tablets (A A H Pharmaceuticals Ltd)
Ondansetron 8mg orodispersible tablets (Alliance Healthcare (Distribution) Ltd)
Ondansetron 8mg orodispersible tablets (Healthcare Pharma Ltd)
Ondansetron 8mg orodispersible tablets (Medihealth (Northern) Ltd)
Ondansetron 8mg orodispersible tablets (Morningside Healthcare Ltd)
Ondansetron 8mg orodispersible tablets (Sigma Pharmaceuticals Plc)
Ondansetron 8mg orodispersible tablets (Zentiva Pharma UK Ltd)

Ondansetron 8mg tablets

Use with caution

Stability notes for Ondansetron 8mg tablets

Light sensitive medicine. Store in light resistant container.   Moisture sensitive medicine. Store in airtight (sealed) MCA.  Manufacturer recommends storing in original container. No stability data in MCAs available.

Provenance

This recommendation is based on the products ondansetron 8mg tablets (Aurobindo Pharma - Milpharm Ltd) and ondansetron 4mg and 8mg tablets (Cipla EU Ltd).

Suppliers (13) of Ondansetron 8mg tablets
Ondansetron 8mg tablets (A A H Pharmaceuticals Ltd)
Ondansetron 8mg tablets (Alissa Healthcare Research Ltd)
Ondansetron 8mg tablets (Alliance Healthcare (Distribution) Ltd)
Ondansetron 8mg tablets (Almus Pharmaceuticals Ltd)
Ondansetron 8mg tablets (Bristol Laboratories Ltd)
Ondansetron 8mg tablets (Cipla EU Ltd)
Ondansetron 8mg tablets (Crescent Pharma Ltd)
Ondansetron 8mg tablets (Medihealth (Northern) Ltd)
Ondansetron 8mg tablets (Milpharm Ltd)
Ondansetron 8mg tablets (Phoenix Healthcare Distribution Ltd)
Ondansetron 8mg tablets (Relonchem Ltd)
Ondansetron 8mg tablets (Sigma Pharmaceuticals Plc)
Ondansetron 8mg tablets (Teva UK Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.